Oruka Therapeutics, Inc.

ORKA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $8.7M $7.4M $38.8M $15.4M $16.8M $2.9M $5.9M $7.0M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $12.3M $21.4M $38.9M $15.5M $16.9M $3.0M $6.2M $7.2M
Property, Plant & Equipment $42.0K $66.0K $28.0K $36.0K $29.0K $23.0K $66.0K $690.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $12.4M $24.6M $39.6M $16.1M $17.1M $3.2M $6.5M $8.2M
Liabilities
Accounts Payable $622.0K $1.2M $364.0K $795.0K $597.0K $65.0K $260.0K $388.0K
Total Current Liabilities $2.1M $2.4M $1.5M $1.4M $1.5M $305.0K $754.0K $1.2M
Long-Term Debt — — — — — — — —
Total Liabilities $2.1M $2.4M $1.5M $1.4M $1.5M $305.0K $770.0K $1.4M
Stockholders' Equity
Retained Earnings $-131.0M $-112.5M $-96.1M $-84.6M $-74.9M $-68.0M $-63.7M $-58.3M
Total Stockholders' Equity $10.3M $22.2M $38.1M $14.7M $15.6M $2.9M $5.7M $6.8M
← Newer Page 2 of 2 Older →